ACHIEVE LIFE SCIENCES, INC. Insider Trading for March 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACHIEVE LIFE SCIENCES, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACHIEVE LIFE SCIENCES, INC. for March 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | Wyrick Susan D. | PAO | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | Wyrick Susan D. | PAO | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | Wyrick Susan D. | PAO | Option Exercise | A | 11.79 | 10,000 | 117,900 | 10,000 | |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | Wyrick Susan D. | PAO | Option Exercise | M | 0.00 | 516 | 0 | 1,547 | |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | Wyrick Susan D. | PAO | Sell | S | 12.25 | 182 | 2,230 | 1,312 | 1.5 K to 1.3 K (-12.18 %) |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | Wyrick Susan D. | PAO | Buy | M | 0.00 | 516 | 0 | 1,494 | 978 to 1.5 K (+52.76 %) |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 0.00 | 12,500 | 0 | 12,500 | |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | A | 11.79 | 25,000 | 294,750 | 25,000 | |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 2,500 | 0 | 7,500 | |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Option Exercise | M | 0.00 | 1,875 | 0 | 3,750 | |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Sell | S | 12.25 | 1,250 | 15,313 | 28,905 | 30.2 K to 28.9 K (-4.15 %) |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | JACOBS CINDY | EVP, CMO | Buy | M | 0.00 | 4,375 | 0 | 30,155 | 25.8 K to 30.2 K (+16.97 %) |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | A | 0.00 | 40,000 | 0 | 40,000 | |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | A | 11.79 | 50,000 | 589,500 | 50,000 | |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 4,688 | 0 | 14,062 | |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Option Exercise | M | 0.00 | 4,688 | 0 | 9,374 | |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Sell | S | 12.25 | 4,634 | 56,767 | 64,980 | 69.6 K to 65 K (-6.66 %) |
Mar 18 2014 | OGXI | ONCOGENEX PHARMACE ... | Cormack Scott Daniel | President and CEO | Buy | M | 0.00 | 9,376 | 0 | 69,614 | 60.2 K to 69.6 K (+15.56 %) |